In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

European Heart Journal - Cardiovascular Pharmacotherapy

Cardiovascular Pharmacology and Pharmacotherapy

Specific focus on clinical cardiovascular pharmacology

Why a new journal?

Pharmacology is an extremely important part of cardiology today. Nearly every patient with cardiac disease is on some kind of medication. Already there are almost half a million references to ‘cardiovascular pharmacology’ in MEDLINE and the number of papers within this area is growing very fast. More studies are needed to improve outcomes of patients with cardiovascular disease, which is the most common cause of death globally.

Mission Statement:

The official journal of the ESC Working Group on Cardiovascular Pharmacotherapy and a brand new addition to the ESC Journal Family, EHJ - Cardiovascular Pharmacotherapy aims to publish reports specifically describing clinical research relevant to cardiovascular drug therapy.

Contribute to the success of this brand new journal

Submit your paper

Visit the journal's home page 

EHJ: Cardiovascular Pharmacotherapy information

ISSN 2055-6837
Volume 2 - year 2016
4 issues

2017 Special rates

ESC Members

Combined (print & online): €40

Members of Working Group on Cardiovascular Pharmacotherapy Combined (print & online): €30



Professor Stefan Agewall, (NO), MD PhD, FESC, FACC, is senior consultant and professor of cardiology at Oslo University Hospital. More than 170 peer-reviewed publications in the cardiovascular field. Chairman of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology 2014-2016. Senior Consulting Editor of  the European Heart Journal. Board member of the European Society of Cardiology Committee for Practice Guidelines and Editorial board member of the European Heart Journal.

Editorial Board

An expert and respected editorial board has been recruited from across the globe, including:

Angeles Alonso, Spain
Jeroen J Bax, the Netherlands
John Beltrame, Australia
Deepak L. Bhatt, US
Eugene Braunwald, US
John Camm, UK
Robin Choudhury, UK
Raffaele De Caterina, Italy
Claudio Ceconi, Italy
Robert Doughty, New Zealand
Heinz Drexel, Austria
Pasquale Perrone Filardi, Italy
Gerasimos Filippatos, Greece
Christian Funck-Brentano, France
Wolfgang-Michael Franz, Austria
Evangelos Giannitsis, Germany
Robert P Giugliano, US
Shinya Goto, Japan
Stefan Hohnloser, Germany
Bernard Gersh, US
Chris Granger, US
Steen Husted, Denmark
Stefan James, Sweden
Juan Carlos Kaski, UK
John J.P. Kastelein, the Netherlands
Sverre Kjeldsen, Norway
Gregory Lip, UK
Alexander Niessner, Austria
Lionel Opie, South Africa
Atul Pathak, France
Fausto Pinto, Portugal
Bertram Pitt, US
Guiseppe Rosano, UK
Luis Ruilope, Spain
Marc S. Sabatine, US
Raul Santos, Brazil
Gaetano Santulli, US
Harald Schmidt, the Netherlands
Udo Sechtem, Germany
Tabassome Simon, France
Philippe Gabriel Steg, France
Juan Tamargo, Spain
Christian Torp Pedersen, Denmark
Hung-Fat Tse, Hong Kong China
Wiek H van Gilst, the Netherlands
Thomas Walther, Ireland
Morten Wang Fagerlund, Norway
Sven Wassmann, Germany
Petr Widimsky, Czech Republic
Harvey White, New Zealand
José Luis Zamorano, Spain
Faiez Zannad, France

Most recent articles from EHJ-CVP